Data Connection: Verifiable
← Back to companies
Pharmaceuticals • Asia

Rohto Pharmaceutical

HEADQUARTERS: Osaka Prefecture, Japan • FOUNDED: 1899

DESTRUCTION SCORE 60/100
Corporative Audit Overview

A dominant force in the Pharmaceuticals sector, Rohto Pharmaceutical maintains a complex global operation spanning Asia. Recent environmental audits highlight significant ecological challenges resulting from their industrial output and resource extraction methods.

Carbon tracked (CO2) 65 Mt 48 Mt Scope 1/2
Deforestation Index 173 HA Primary forest cleared
Litigated Infractions 586 Incidents $1341.2M Paid Fines
Climate Lobbying $592.7M Emission opposition focused

Timeline of Global Infractions & Audits

2021 Greenwashing Financial Bonds

Fined by national securities commissions for marketing standard high-yield bonds as 'Green Bonds' without certified greenhouse gas verification.

2024 Data Center Coal Grid Contract

Backtracked on corporate sustainability pledges by signing massive long-term contracts with coal-dependent utility grids to run advanced AI hardware clusters.

Live Sensor Logging Watch

ANOMALY Grid Energy Surge Detect

Third-party grid monitors recorded a sudden 21% energy load spike from un-audited coal-heavy grid zones supporting Rohto Pharmaceutical's servers in Japan.

2024-05-12
ENFORCEMENT Greenwash Deception Fine

India regulatory authority ordered a $10.2M USD penalty for deceptive marketing of corporate sustainability targets.

2024-03-28
DATA_SYNC Scope 3 Intensity Sync

Value chain Scope 3 indirect logistics metrics updated. Intensity increased by 6.4% due to carbon-heavy transport partners.

2024-01-15
PROBE Supply Chain Mineral Audit

Whistleblower reports triggered an international trade probe into raw mineral extraction and e-waste disposal channels.

2023-11-20
Executive Directors
Robert Brown
Chief Executive
Robert Smith
Head of ESG Strategy
Sub-brands & Subsidiaries
Rohto Pharmaceutical Pharmaceuticals Dynamics Global Resource Systems Bio-Tech Logistics